GlassScriptPhysician profile
Sarah Maruna
NPI 1609313527
$1,382.63
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $877 · 2022: $471 · 2023: $34.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $365.85 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $218.79 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $165.20 | 2022 | |
| Janssen Pharmaceuticals, INC | $143.17 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $107.40 | 2021-2022 | |
| Lundbeck LLC | $95.54 | 2021 | |
| Alkermes, INC. | $81.31 | 2021-2023 | Lybalvi |
| Teva Pharmaceuticals USA, INC. | $78.40 | 2021-2023 | Austedo |
| Adlon Therapeutics L.P. | $26.00 | 2021 | |
| Eisai INC. | $24.51 | 2021 | |
| Sunovion Pharmaceuticals INC. | $18.39 | 2021 | |
| Orexo US, INC. | $17.97 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.33 | 2021 | |
| Neurocrine Biosciences, INC. | $14.04 | 2021 | |
| Boston Scientific Corporation | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Maruna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.